agilon health inc
NYSE:AGL
agilon health inc
NYSE:AGL
Price:
5.38 USD
7.39%
Market Closed
Updated:
Apr 19, 2024
Section:
Relative Value
The Relative Value of one
AGL
stock under the Base Case scenario is
48.46
USD.
Compared to the current market price of 5.38 USD,
agilon health inc
is
Undervalued by 89%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
AGL
Relative Value
Base Case
48.46
USD
Undervaluation 89%
Valuation Multiples
Multiples Across Competitors
AGL Competitors Multiples
agilon health inc Competitors
agilon health inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
agilon health inc
NYSE:AGL
|
2.2B USD | 0.5 | -8.3 | -8.2 | -7.5 | |
| US |
|
Cigna Corp
NYSE:CI
|
102B USD | 0.5 | 19.8 | 10.2 | 13.6 | |
| US |
C
|
Cigna Group
XMUN:CGN
|
95.5B EUR | 0.5 | 19.7 | 10.1 | 13.5 | |
| US |
|
CVS Health Corp
NYSE:CVS
|
89.4B USD | 0.2 | 10.7 | 9.1 | 9.1 | |
| DE |
|
Fresenius Medical Care AG
XMUN:FME
|
20.8B EUR | 1.1 | 41.8 | 9.9 | 23.6 | |
| US |
|
Laboratory Corporation of America Holdings
NYSE:LH
|
16.7B USD | 1.4 | 40 | 12 | 18.1 | |
| DE |
F
|
Fresenius SE & Co KGaA
XETRA:FRE
|
15B EUR | 0.7 | -25.3 | 9.8 | 22 | |
| US |
|
Quest Diagnostics Inc
NYSE:DGX
|
14B USD | 1.5 | 16.4 | 10.1 | 13.4 | |
| DE |
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
10.7B EUR | 0.5 | 21.4 | 6.6 | 15.6 | |
| US |
|
DaVita Inc
NYSE:DVA
|
11.2B USD | 0.9 | 16.2 | 8.1 | 11.9 | |
| US |
|
Oak Street Health Inc
NYSE:OSH
|
9.5B USD | 4.4 | -18.6 | -23.3 | -21.5 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
